founders raise stake
** Biopharma company's shares ACXP.O rise 6.3% to $5.9
after the bell
** Top investors and co-founders Robert DeLuccia and David
Luci raise stakes to 13% and 13.2%, respectively
** Luci held 10.87%, while DeLuccia owned 10.55% as of June
25 - Refinitiv data,
** Stock debuted on the Nasdaq on June 25 and has fallen 25%
from its IPO price
(Reporting by Dania Nadeem in Bengaluru)
((Dania.Nadeem@thomsonreuters.com;))
Recent news on Acurx Pharmaceuticals
See all newsAcurx Pharmaceuticals Q1 net loss narrows as expenses fall
Brief: Acurx Pharmaceuticals To Discuss First Quarter 2026 Financial Results On May 12, 2026 Conference Call And Provide Business Update
Brief: Acurx Pharmaceuticals, Inc. Announces Closing Of Up To $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Acurx Pharmaceuticals Q4 net loss narrows on lower R&D spend
Acurx Pharma Q3 net loss narrows to $2 mln